Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Accretion Pharmaceuticals Limited (NSE: ACCPL), ISIN INE0T8T01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ACCPL last traded at ₹201.70 (-3.95%), with a 52-week range of ₹57.10 to ₹220.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 73.52%, FIIs 0.17%, DIIs 3.65%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.